Intravitreal injection of endothelin-1 caused optic nerve damage following to ocular hypoperfusion in rabbits

Experimental Eye Research

Volumn 83, Issue 3, 2006, Pages 629-637

  Sasaoka, Masaaki ^a   Taniguchi, Takazumi ^a   Shimazawa, Masamitsu ^b   Ishida, Naruhiro ^a   Shimazaki, Atsushi ^a   Hara, Hideaki ^b  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

endothelin 1; hypoperfusion; ischemia; neurofilament; optic nerve; rabbit

Indexed keywords

ENDOTHELIN 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BLOOD FLOW VELOCITY; CILIARY DISK; CONTROLLED STUDY; EYE FUNDUS; GLIOSIS; IMMUNOBLOTTING; INTRAOCULAR HYPOPERFUSION; MYELINATED NERVE; NERVE FIBER; NEUROFILAMENT; NONHUMAN; OPTIC NERVE; OPTIC NERVE LESION; PERFUSION; PRIORITY JOURNAL; RABBIT; RETINA ARTERY; RETINA GANGLION CELL; RETINA INJURY; RETINA ISCHEMIA;

ANIMALS; AXONS; BLOOD FLOW VELOCITY; CELL COUNT; ENDOTHELIN-1; IMMUNOBLOTTING; INJECTIONS; INTRAOCULAR PRESSURE; NEUROFILAMENT PROTEINS; OPTIC DISK; OPTIC NEUROPATHY, ISCHEMIC; RABBITS; RETINA; RETINAL ARTERY; TIME FACTORS; VITREOUS BODY;

EID: 33745132096     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2006.03.007     Document Type: Article

References (52)

1. Briers J.D., and Fercher A.F. Retinal blood-flow visualization by means of laser speckle photography. Invest. Ophthalmol. Vis. Sci. 22 (1982) 255-259
2. Brooks D.E., Kallberg M.E., Cannon R.L., Komaromy A.M., Ollivier F.J., Malakhova O.E., Dawson W.W., Sherwood M.B., Kuekuerichkina E.E., and Lambrou G.N. Functional and structural analysis of the visual system in the rhesus monkey model of optic nerve head ischemia. Invest. Ophthalmol. Vis. Sci. 45 (2004) 1830-1840
3. Cellini M., Possati G.L., Profazio V., Sbrocca M., Caramazza N., and Caramazza R. Color Doppler imaging and plasma levels of endothelin-1 in low-tension glaucoma. Acta Ophthalmol. Scand. Suppl. (1997) 11-13
4. Chauhan B.C., LeVatte T.L., Jollimore C.A., Yu P.K., Reitsamer H.A., Kelly M.E., Yu D.Y., Tremblay F., and Archibald M.L. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest. Ophthalmol. Vis. Sci. 45 (2004) 144-152
5. Chidlow G., and Osborne N.N. Rat retinal ganglion cell loss caused by kainate, NMDA and ischemia correlates with a reduction in mRNA and protein of Thy-1 and neurofilament light. Brain Res. 963 (2003) 298-306
6. Cioffi G.A., and Sullivan P. The effect of chronic ischemia on the primate optic nerve. Eur. J. Ophthalmol. 9 Suppl. 1 (1999) S34-S36
7. Cioffi G.A., Orgul S., Onda E., Bacon D.R., and Van Buskirk E.M. An in vivo model of chronic optic nerve ischemia: the dose-dependent effects of endothelin-1 on the optic nerve microvasculature. Curr. Eye Res. 14 (1995) 1147-1153
8. Cioffi G.A., Wang L., Fortune B., Cull G., Dong J., Bui B., and Van Buskirk E.M. Chronic ischemia induces regional axonal damage in experimental primate optic neuropathy. Arch. Ophthalmol. 122 (2004) 1517-1525
9. Flammer J. The vascular concept of glaucoma. Surv. Ophthalmol. 38 Suppl. (1994) S3-S6
10. Fujii H., Nohira K., Yamamoto Y., Ikawa H., and Ohura T. Evaluation of blood flow by laser speckle image sensing. Part 1. Appl. Opt. 26 (1987) 5321-5325
11. Goldenberg-Cohen N., Guo Y., Margolis F., Cohen Y., Miller N.R., and Bernstein S.L. Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischemia. Invest. Ophthalmol. Vis. Sci. 46 (2005) 2716-2725
12. Goodman J.W. Statistical properties of laser speckle patterns. In: Danity J.C. (Ed). Laser Speckle and Related Phenomena (1975), Springer-Verlag, New York 9-75
13. Harris A., Arend O., Chung H.S., Kagemann L., Cantor L., and Martin B. A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal-tension glaucoma patients. Ophthalmology 107 (2000) 430-434
14. Hasselblatt M., Bunte M., Dringen R., Tabernero A., Medina J.M., Giaume C., Siren A.L., and Ehrenreich H. Effect of endothelin-1 on astrocytic protein content. Glia 42 (2003) 390-397
15. Hollo G., Lakatos P., and Farkas K. Cold pressor test and plasma endothelin-1 concentration in primary open-angle and capsular glaucoma. J. Glaucoma. 7 (1998) 105-110
16. Hughes A. A schematic eye for the rat. Vis. Res. 19 (1979) 569-588
17. Iwase A., Suzuki Y., Araie M., Yamamoto T., Abe H., Shirato S., Kuwayama Y., Mishima H.K., Shimizu H., Tomita G., Inoue Y., and Kitazawa Y. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111 (2004) 1641-1648
18. Julien J.P., and Mushynski W.E. Neurofilaments in health and disease. Prog. Nucleic Acid Res. Mol. Biol. 61 (1998) 1-23
19. Kaiser H.J., Flammer J., Wenk M., and Luscher T. Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes. Graefes Arch. Clin. Exp. Ophthalmol. 233 (1995) 484-488
20. Kashiwagi K., Ou B., Nakamura S., Tanaka Y., Suzuki M., and Tsukahara S. Increase in dephosphorylation of the heavy neurofilament subunit in the monkey chronic glaucoma model. Invest. Ophthalmol. Vis. Sci. 44 (2003) 154-159
21. Levene R.Z. Low tension glaucoma: a critical review and new material. Surv. Ophthalmol. 24 (1980) 621-664
22. Levesque H., Moore N., Cailleux N., Richard V., Thuillez C., and Courtois H. Endothelins. A potential target for pharmacological intervention in diseases of the elderly. Drugs Aging 4 (1994) 221-237
23. Luscher T.F. Endothelin. J. Cardiovasc. Pharmacol. 18 Suppl. 10 (1991) S15-S22
24. MacCumber M.W., Jampel H.D., and Snyder S.H. Ocular effects of the endothelins. Abundant peptides in the eye. Arch. Ophthalmol. 109 (1991) 705-709
25. Nicolela M.T., Ferrier S.N., Morrison C.A., Archibald M.L., LeVatte T.L., Wallace K., Chauhan B.C., and LeBlanc R.P. Effects of cold-induced vasospasm in glaucoma: the role of endothelin-1. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2565-2572
26. Nixon R.A., and Sihag R.K. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci. 14 (1991) 501-506
27. Noske W., Hensen J., and Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract. Graefes Arch. Clin. Exp. Ophthalmol. 235 (1997) 551-552
28. Oku H., Sugiyama T., Kojima S., Watanabe T., and Azuma I. Experimental optic cup enlargement caused by endothelin-1-induced chronic optic nerve head ischemia. Surv. Ophthalmol. 44 Suppl. 1 (1999) S74-S84
29. Orgul S., Cioffi G.A., Bacon D.R., and Van Buskirk E.M. An endothelin-1-induced model of chronic optic nerve ischemia in rhesus monkeys. J. Glaucoma. 5 (1996) 135-138
30. Orgul S., Cioffi G.A., Wilson D.J., Bacon D.R., and Van Buskirk E.M. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1860-1869
31. Pang I.H., and Yorio T. Ocular actions of endothelins. Proc. Soc. Exp. Biol. Med. 215 (1997) 21-34
32. Prasanna G., Krishnamoorthy R., Clark A.F., Wordinger R.J., and Yorio T. Human optic nerve head astrocytes as a target for endothelin-1. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2704-2713
33. Quigley H.A. Open-angle glaucoma. N. Engl. J. Med. 328 (1993) 1097-1106
34. Rao M.V., and Nixon R.A. Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review. Neurochem. Res. 28 (2003) 1041-1047
35. Rubanyi G.M., and Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46 (1994) 325-415
36. Sakaguchi T., Okada M., Kitamura T., and Kawasaki K. Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail. Neurosci. Lett. 153 (1993) 65-68
37. Schmetterer L., Findl O., Strenn K., Jilma B., Graselli U., Eichler H.G., and Wolzt M. Effects of endothelin-1 (ET-1) on ocular hemodynamics. Curr. Eye Res. 16 (1997) 687-692
38. Shields D.C., Leblanc C., and Banik N.L. Calcium-mediated neurofilament protein degradation in rat optic nerve in vitro: activity and autolysis of calpain proenzyme. Exp. Eye Res. 65 (1997) 15-21
39. Shiose Y., Kitazawa Y., Tsukahara S., Akamatsu T., Mizokami K., Futa R., Katsushima H., and Kosaki H. Epidemiology of glaucoma in Japan-a nationwide glaucoma survey. Jpn. J. Ophthalmol. 35 (1991) 133-155
40. Stamer K., Vogel R., Thies E., Mandelkow E., and Mandelkow E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156 (2002) 1051-1063
41. Stokely M.E., Brady S.T., and Yorio T. Effects of endothelin-1 on components of anterograde axonal transport in optic nerve. Invest. Ophthalmol. Vis. Sci. 43 (2002) 3223-3230
42. Stokely M.E., Yorio T., and King M.A. Endothelin-1 modulates anterograde fast axonal transport in the central nervous system. J. Neurosci. Res. 79 (2005) 598-607
43. Strenn K., Matulla B., Wolzt M., Findl O., Bekes M.C., Lamsfuss U., Graselli U., Rainer G., Menapace R., Eichler H.G., and Schmetterer L. Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans. Clin. Pharmacol. Ther. 63 (1998) 54-63
44. Sugiyama T., Moriya S., Oku H., and Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv. Ophthalmol. 39 Suppl. 1 (1995) S49-S56
45. Tamaki Y., Araie M., Kawamoto E., Eguchi S., and Fujii H. Non-contact, two-dimensional measurement of tissue circulation in choroid and optic nerve head using laser speckle phenomenon. Exp. Eye Res. 60 (1995) 373-383
46. Taniguchi T., Shimazawa M., and Hara H. Alterations in neurofilament light in optic nerve in rat kainate and monkey ocular hypertension models. Brain Res. 1013 (2004) 241-248
47. i mobilization of cells in human ciliary smooth muscle, ciliary non-pigmented epithelium, and trabecular meshwork. Curr. Eye Res. 17 (1998) 31-38
48. Tezel G., Kass M.A., Kolker A.E., Becker B., and Wax M.B. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J. Glaucoma. 6 (1997) 83-89
49. Tomita G., Niwa Y., Shinohara H., Hayashi N., Yamamoto T., and Kitazawa Y. Changes in optic nerve head blood flow and retrobular hemodynamics following calcium-channel blocker treatment of normal-tension glaucoma. Int. Ophthalmol. 23 (1999) 3-10
50. Vickers J.C., Schumer R.A., Podos S.M., Wang R.F., Riederer B.M., and Morrison J.H. Differential vulnerability of neurochemically identified subpopulations of retinal neurons in a monkey model of glaucoma. Brain Res. 680 (1995) 23-35
51. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
52. Yoneda S., Tanaka E., Goto W., Ota T., and Hara H. Topiramate reduces excitotoxic and ischemic injury in the rat retina. Brain Res. 967 (2003) 257-266